Concepedia

Luke Maggs

LM

Statistics

Publications

9

Citations

254

H-Index

9

Active since

2017

Affiliations

Massachusetts General Hospital(Current)

Harvard University

University of Birmingham

Cedars-Sinai Medical Center

Broad Institute

Luke Maggs is an author at Massachusetts General Hospital specializing in immunology, antitumor t cell responses, and oncology.

ORCID

Publications per year

2017–2025

9

Publications

9

NK cells produce high levels of IL‐10 early after allogeneic stem cell transplantation and suppress development of acute GVHD

Y L Tracey Chan, Jianmin Zuo, Charlotte Inman et al. · European Journal of Immunology · 2017 · 43 citations · Full text

, , +17

B7-H3 targeted antibody-based immunotherapy of malignant diseases

Theodoros Michelakos, Filippos Kontos, Omar Barakat et al. · Expert Opinion on Biological Therapy · 2020 · 39 citations · Full text

, , +16

Mixed chimerism established by hematopoietic stem cell transplantation is maintained by host and donor T regulatory cells

Francesca Kinsella, Jianmin Zuo, Charlotte Inman et al. · Blood Advances · 2019 · 34 citations · Full text

, , +16

The number of CD56dim NK cells in the graft has a major impact on risk of disease relapse following allo-HSCT

Luke Maggs, Francesca Kinsella, Y L Tracey Chan et al. · Blood Advances · 2017 · 29 citations · Full text

, , +11

Chimeric Antigen Receptor T Cell with an Inducible Caspase-9 Suicide Gene Eradicates Uveal Melanoma Liver Metastases via B7-H3 Targeting

Marco Ventin, Giulia Cattaneo, Shahrzad Arya et al. · Clinical Cancer Research · 2024 · 28 citations · Full text

, , +17

1–5 of 9